BSX logo

Boston Scientific (BSX) Operating profit

annual operating profit:

$3.00B+$585.00M(+24.20%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BSX annual operating income is $3.00 billion, with the most recent change of +$585.00 million (+24.20%) on December 1, 2024.
  • During the last 3 years, BSX annual operating profit has risen by +$1.18 billion (+64.58%).
  • BSX annual operating profit is now at all-time high.

Performance

BSX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

quarterly operating profit:

$788.00M+$70.00M(+9.75%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BSX quarterly operating income is $788.00 million, with the most recent change of +$70.00 million (+9.75%) on December 1, 2024.
  • Over the past year, BSX quarterly operating profit has increased by +$70.00 million (+9.75%).
  • BSX quarterly operating profit is now -25.87% below its all-time high of $1.06 billion, reached on March 31, 2011.

Performance

BSX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

TTM operating profit:

$3.00B+$171.00M(+6.05%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BSX TTM operating income is $3.00 billion, with the most recent change of +$171.00 million (+6.05%) on December 1, 2024.
  • Over the past year, BSX TTM operating profit has increased by +$171.00 million (+6.05%).
  • BSX TTM operating profit is now at all-time high.

Performance

BSX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

BSX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.2%+9.8%+6.0%
3 y3 years+64.6%+29.8%+34.9%
5 y5 years+72.5%+29.8%+34.9%

BSX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+64.6%-1.4%+63.5%at high+54.8%
5 y5-yearat high+338.9%-1.4%+2487.9%at high+338.3%
alltimeall timeat high+4158.2%-25.9%+241.0%at high>+9999.0%

Boston Scientific Operating profit History

DateAnnualQuarterlyTTM
Dec 2024
$3.00B(+24.2%)
$788.00M(+9.7%)
$3.00B(+6.0%)
Sep 2024
-
$718.00M(-10.1%)
$2.83B(+4.0%)
Jun 2024
-
$799.00M(+15.3%)
$2.72B(+7.6%)
Mar 2024
-
$693.00M(+12.3%)
$2.53B(+4.6%)
Dec 2023
$2.42B(+18.9%)
$617.00M(+1.3%)
$2.42B(+3.9%)
Sep 2023
-
$609.00M(+0.3%)
$2.33B(+4.6%)
Jun 2023
-
$607.00M(+4.1%)
$2.22B(+4.2%)
Mar 2023
-
$583.00M(+10.8%)
$2.13B(+5.0%)
Dec 2022
$2.03B(+11.5%)
$526.00M(+3.7%)
$2.03B(+2.4%)
Sep 2022
-
$507.00M(-2.1%)
$1.99B(+2.5%)
Jun 2022
-
$518.00M(+7.5%)
$1.94B(-0.2%)
Mar 2022
-
$482.00M(+0.6%)
$1.94B(+6.4%)
Dec 2021
$1.82B(+166.7%)
$479.00M(+4.6%)
$1.82B(+18.9%)
Sep 2021
-
$458.00M(-12.1%)
$1.53B(+13.0%)
Jun 2021
-
$521.00M(+42.3%)
$1.36B(+68.9%)
Mar 2021
-
$366.00M(+93.7%)
$804.00M(+17.5%)
Dec 2020
$684.00M(-60.7%)
$189.00M(-33.0%)
$684.00M(-26.5%)
Sep 2020
-
$282.00M(-954.5%)
$930.00M(-12.8%)
Jun 2020
-
-$33.00M(-113.4%)
$1.07B(-31.0%)
Mar 2020
-
$246.00M(-43.4%)
$1.55B(-11.0%)
Dec 2019
$1.74B(+4.9%)
$435.00M(+3.8%)
$1.74B(+1.4%)
Sep 2019
-
$419.00M(-6.3%)
$1.72B(+1.3%)
Jun 2019
-
$447.00M(+2.1%)
$1.69B(+1.3%)
Mar 2019
-
$438.00M(+6.6%)
$1.67B(+0.7%)
Dec 2018
$1.66B(+8.4%)
$411.00M(+3.5%)
$1.66B(-0.9%)
Sep 2018
-
$397.00M(-6.8%)
$1.68B(+1.3%)
Jun 2018
-
$426.00M(-0.2%)
$1.66B(+1.2%)
Mar 2018
-
$427.00M(+0.2%)
$1.64B(+6.9%)
Dec 2017
$1.53B(+16.1%)
$426.00M(+13.3%)
$1.53B(+6.8%)
Sep 2017
-
$376.00M(-7.6%)
$1.43B(+1.8%)
Jun 2017
-
$407.00M(+26.8%)
$1.41B(+5.7%)
Mar 2017
-
$321.00M(-2.1%)
$1.33B(+0.8%)
Dec 2016
$1.32B(+33.2%)
$328.00M(-6.6%)
$1.32B(+7.8%)
Sep 2016
-
$351.00M(+6.0%)
$1.22B(+8.9%)
Jun 2016
-
$331.00M(+6.8%)
$1.12B(+7.9%)
Mar 2016
-
$310.00M(+33.6%)
$1.04B(+5.3%)
Dec 2015
$990.00M(+9.8%)
$232.00M(-7.6%)
$990.00M(0.0%)
Sep 2015
-
$251.00M(+0.8%)
$990.00M(+4.0%)
Jun 2015
-
$249.00M(-3.5%)
$952.00M(+2.4%)
Mar 2015
-
$258.00M(+11.2%)
$930.00M(+3.0%)
Dec 2014
$902.00M(+2.0%)
$232.00M(+8.9%)
$903.00M(+2.4%)
Sep 2014
-
$213.00M(-6.2%)
$882.00M(-0.9%)
Jun 2014
-
$227.00M(-1.7%)
$890.00M(-2.2%)
Mar 2014
-
$231.00M(+9.5%)
$910.00M(+3.1%)
Dec 2013
$884.00M(-5.0%)
$211.00M(-4.5%)
$883.00M(-2.3%)
Sep 2013
-
$221.00M(-10.5%)
$904.00M(-2.1%)
Jun 2013
-
$247.00M(+21.1%)
$923.00M(+0.5%)
Mar 2013
-
$204.00M(-12.1%)
$918.00M(-1.3%)
Dec 2012
$931.00M(-5.8%)
$232.00M(-3.3%)
$930.00M(+569.1%)
Sep 2012
-
$240.00M(-0.8%)
$139.00M(+26.4%)
Jun 2012
-
$242.00M(+12.0%)
$110.00M(-22.5%)
Mar 2012
-
$216.00M(-138.6%)
$142.00M(-85.6%)
Dec 2011
$988.00M(-0.2%)
-$559.00M(-364.9%)
$989.00M(-45.4%)
Sep 2011
-
$211.00M(-23.0%)
$1.81B(-2.7%)
Jun 2011
-
$274.00M(-74.2%)
$1.86B(+2.6%)
Mar 2011
-
$1.06B(+302.7%)
$1.81B(+83.5%)
Dec 2010
$990.00M(-19.1%)
$264.00M(+1.1%)
$989.00M(-35.8%)
Sep 2010
-
$261.00M(+15.0%)
$1.54B(+15.0%)
Jun 2010
-
$227.00M(-4.2%)
$1.34B(-6.2%)
Mar 2010
-
$237.00M(-71.0%)
$1.43B(+16.6%)
Dec 2009
$1.22B(+5.9%)
$816.00M(+1260.0%)
$1.23B(+83.4%)
Sep 2009
-
$60.00M(-81.0%)
$668.00M(+20.8%)
Jun 2009
-
$315.00M(+826.5%)
$553.00M(-2.5%)
Mar 2009
-
$34.00M(-86.9%)
$567.00M(-37.3%)
Dec 2008
$1.16B(+82.6%)
$259.00M(-570.9%)
$905.00M(+14.4%)
Sep 2008
-
-$55.00M(-116.7%)
$791.00M(+2.2%)
Jun 2008
-
$329.00M(-11.6%)
$774.00M(+7.9%)
Mar 2008
-
$372.00M(+156.6%)
$717.00M(+14.4%)
DateAnnualQuarterlyTTM
Dec 2007
$633.00M(-45.9%)
$145.00M(-301.4%)
$627.00M(-18.4%)
Sep 2007
-
-$72.00M(-126.5%)
$768.00M(-25.8%)
Jun 2007
-
$272.00M(-3.5%)
$1.03B(+8.4%)
Mar 2007
-
$282.00M(-1.4%)
$955.00M(-18.4%)
Dec 2006
$1.17B(-5.9%)
$286.00M(+46.7%)
$1.17B(-13.3%)
Sep 2006
-
$195.00M(+1.6%)
$1.35B(+64.9%)
Jun 2006
-
$192.00M(-61.4%)
$818.00M(-29.2%)
Mar 2006
-
$497.00M(+6.9%)
$1.16B(-7.2%)
Dec 2005
$1.24B(-24.1%)
$465.00M(-238.4%)
$1.24B(-3.1%)
Sep 2005
-
-$336.00M(-163.5%)
$1.28B(-35.1%)
Jun 2005
-
$529.00M(-9.7%)
$1.98B(+0.9%)
Mar 2005
-
$586.00M(+16.0%)
$1.96B(+19.6%)
Dec 2004
$1.64B(+123.3%)
$505.00M(+41.1%)
$1.64B(+22.9%)
Sep 2004
-
$358.00M(-30.1%)
$1.33B(+15.3%)
Jun 2004
-
$512.00M(+93.9%)
$1.16B(+39.4%)
Mar 2004
-
$264.00M(+32.0%)
$830.00M(+13.1%)
Dec 2003
$734.00M(+5.6%)
$200.00M(+10.5%)
$734.00M(+0.4%)
Sep 2003
-
$181.00M(-2.2%)
$731.00M(-8.2%)
Jun 2003
-
$185.00M(+10.1%)
$796.00M(+7.9%)
Mar 2003
-
$168.00M(-14.7%)
$738.00M(+6.2%)
Dec 2002
$695.00M(+81.9%)
$197.00M(-19.9%)
$695.00M(-21.4%)
Sep 2002
-
$246.00M(+93.7%)
$884.00M(+19.5%)
Jun 2002
-
$127.00M(+1.6%)
$740.00M(+13.0%)
Mar 2002
-
$125.00M(-67.6%)
$655.00M(+0.9%)
Dec 2001
$382.00M(-43.4%)
$386.00M(+278.4%)
$649.00M(+61.8%)
Sep 2001
-
$102.00M(+142.9%)
$401.00M(-13.6%)
Jun 2001
-
$42.00M(-64.7%)
$464.00M(-24.4%)
Mar 2001
-
$119.00M(-13.8%)
$614.00M(-9.0%)
Dec 2000
$675.00M(-6.9%)
$138.00M(-16.4%)
$675.00M(-7.7%)
Sep 2000
-
$165.00M(-14.1%)
$731.00M(+7.0%)
Jun 2000
-
$192.00M(+6.7%)
$683.00M(-3.3%)
Mar 2000
-
$180.00M(-7.2%)
$706.00M(-2.6%)
Dec 1999
$725.00M(+47.7%)
$194.00M(+65.8%)
$725.00M(+4.8%)
Sep 1999
-
$117.00M(-45.6%)
$692.00M(-0.3%)
Jun 1999
-
$215.00M(+8.0%)
$694.00M(+18.2%)
Mar 1999
-
$199.00M(+23.6%)
$587.00M(+19.6%)
Dec 1998
$491.00M(+16.4%)
$161.00M(+35.3%)
$491.00M(+30.7%)
Sep 1998
-
$119.00M(+10.2%)
$375.80M(-1.4%)
Jun 1998
-
$108.00M(+4.9%)
$381.30M(-7.5%)
Mar 1998
-
$103.00M(+124.9%)
$412.10M(-2.3%)
Dec 1997
$422.00M(+22.1%)
$45.80M(-63.2%)
$421.90M(+8.3%)
Sep 1997
-
$124.50M(-10.3%)
$389.50M(+4.1%)
Jun 1997
-
$138.80M(+23.0%)
$374.10M(+6.6%)
Mar 1997
-
$112.80M(+741.8%)
$350.90M(+16.0%)
Dec 1996
$345.50M(+34.7%)
$13.40M(-87.7%)
$302.50M(-4.8%)
Sep 1996
-
$109.10M(-5.6%)
$317.60M(+10.6%)
Jun 1996
-
$115.60M(+79.5%)
$287.20M(+16.4%)
Mar 1996
-
$64.40M(+126.0%)
$246.80M(-3.8%)
Dec 1995
$256.50M(+97.3%)
$28.50M(-63.8%)
$256.60M(-3.5%)
Sep 1995
-
$78.70M(+4.7%)
$265.90M(+21.4%)
Jun 1995
-
$75.20M(+1.3%)
$219.00M(+25.5%)
Mar 1995
-
$74.20M(+96.3%)
$174.50M(+34.2%)
Dec 1994
$130.00M(+19.7%)
$37.80M(+18.9%)
$130.00M(+4.9%)
Sep 1994
-
$31.80M(+3.6%)
$123.90M(+4.0%)
Jun 1994
-
$30.70M(+3.4%)
$119.10M(+3.9%)
Mar 1994
-
$29.70M(-6.3%)
$114.60M(+5.6%)
Dec 1993
$108.60M(+17.0%)
$31.70M(+17.4%)
$108.50M(+6.1%)
Sep 1993
-
$27.00M(+3.1%)
$102.30M(+2.6%)
Jun 1993
-
$26.20M(+11.0%)
$99.70M(+4.4%)
Mar 1993
-
$23.60M(-7.5%)
$95.50M(+2.8%)
Dec 1992
$92.80M(+31.6%)
$25.50M(+4.5%)
$92.90M(-428.3%)
Sep 1992
-
$24.40M(+10.9%)
-$28.30M(-493.1%)
Jun 1992
-
$22.00M(+4.8%)
$7.20M(-82.5%)
Mar 1992
-
$21.00M(-121.9%)
$41.10M(-41.8%)
Dec 1991
$70.50M
-$95.70M(-259.8%)
$70.60M(-57.5%)
Sep 1991
-
$59.90M(+7.2%)
$166.30M(+56.3%)
Jun 1991
-
$55.90M(+10.7%)
$106.40M(+110.7%)
Mar 1991
-
$50.50M
$50.50M

FAQ

  • What is Boston Scientific annual operating income?
  • What is the all time high annual operating profit for Boston Scientific?
  • What is Boston Scientific annual operating profit year-on-year change?
  • What is Boston Scientific quarterly operating income?
  • What is the all time high quarterly operating profit for Boston Scientific?
  • What is Boston Scientific quarterly operating profit year-on-year change?
  • What is Boston Scientific TTM operating income?
  • What is the all time high TTM operating profit for Boston Scientific?
  • What is Boston Scientific TTM operating profit year-on-year change?

What is Boston Scientific annual operating income?

The current annual operating profit of BSX is $3.00B

What is the all time high annual operating profit for Boston Scientific?

Boston Scientific all-time high annual operating income is $3.00B

What is Boston Scientific annual operating profit year-on-year change?

Over the past year, BSX annual operating income has changed by +$585.00M (+24.20%)

What is Boston Scientific quarterly operating income?

The current quarterly operating profit of BSX is $788.00M

What is the all time high quarterly operating profit for Boston Scientific?

Boston Scientific all-time high quarterly operating income is $1.06B

What is Boston Scientific quarterly operating profit year-on-year change?

Over the past year, BSX quarterly operating income has changed by +$70.00M (+9.75%)

What is Boston Scientific TTM operating income?

The current TTM operating profit of BSX is $3.00B

What is the all time high TTM operating profit for Boston Scientific?

Boston Scientific all-time high TTM operating income is $3.00B

What is Boston Scientific TTM operating profit year-on-year change?

Over the past year, BSX TTM operating income has changed by +$171.00M (+6.05%)
On this page